MedTrace Logo

Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability

NCT01400854 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2012-10-24

No results posted yet for this study

Summary

Aim of this non-interventional study is to investigate the tolerability of Effentora® in cancer pain patients with breakthrough pain under real-life conditions in clinical practice.

Conditions

Interventions

DRUG

Effentora®

prescribed as per local Summary of Product Characteristics (SmPC) for 4 weeks duration

Sponsors & Collaborators

  • Cephalon

    lead INDUSTRY

Principal Investigators

  • Medical Department · Cephalon

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01400854 on ClinicalTrials.gov